"Intraperitoneal Chemotherapy as a Multimodal Treatment for Gastric Cancer Patients with Peritoneal Metastasis"
written by Sachio Fushida, Katsunobu Oyama, Jun Kinoshita, Tomoya Tsukada, Kouichi Okamoto, Hidehiro Tajima, Itasu Ninomiya, Hirohisa Kitagawa, Takashi Fujimura, Tetsuo Ohta,
published by Journal of Cancer Therapy, Vol.4 No.9A, 2013
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Therapy for gastric cancer with peritoneal metastasis using injectable albumin hydrogel hybridized with paclitaxel-loaded RBC membrane nanoparticles
2019
[2] Multidisciplinary therapy for scirrhous gastric cancer: a retrospective analysis and proposal of new treatment strategy
Cancer management and research, 2018
[3] Adjuvant intraperitoneal chemotherapy for the treatment of colorectal cancer at risk for peritoneal carcinomatosis: a systematic review
Geocarto International, 2017
[4] RegIV 在视网膜母细胞瘤中的表达及其与血管新生的相关性分析
2017
[5] Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis
2017
[6] Low-dose paclitaxel suppresses the induction of M2 macrophages in gastric cancer
2017
[7] 胃癌腹膜转移转化性治疗的临床意义
2016
[8] Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: A systematic review
Journal of surgical oncology, 2016
[9] Exploiting the Antitumor Immune Response Using IL-12 Armed Oncolytic MG1 Virus In An Infected Cell Vaccine
2016
[10] 紫杉醇与替吉奥联合防治胃癌腹膜转移的临床疗效
2015
[11] Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-β signaling pathway
Oncology reports, 2015
[12] 腹腔内化疗对胃癌腹膜转移的临床意义
外科理论与实践, 2015
[13] 胃癌腹膜转移临床诊疗的新进展
世界华人消化杂志, 2015
[14] The Angiotensin II type 1 receptor blocker candesartan suppresses
2015
[15] The Angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer
Cancer letters, 2014